KeyBanc analyst Michael Leshock lowered his rating on Rocket Lab from overweight to sector weight, arguing that the company’s growth prospects are already fully reflected in its share performance. Rocket Lab recently set an intraday record high in early December and has surged more than 350% over the past nine months. Technical indicators show the stock’s 10-day moving average has provided consistent support during pullbacks, contributing to a bullish flag pattern on daily charts. Short interest stands at approximately 7.5% of the available float, down from over 12% a year ago but still notable. Options traders have favored calls over puts, with a 10-day call/put volume ratio of 2.34 across major U.S. exchanges and more than 31,000 calls changing hands in the latest reporting window. The January 2026 95-strike call is the most actively opened contract, followed by the 90-strike series. Schaeffer’s Volatility Scorecard rates RKLB at 79 out of 100, reflecting realized volatility above implied levels and reinforcing elevated investor expectations for further price swings.

Rocket Lab’s upcoming mid-2026 Neutron orbital launch is viewed as a pivotal catalyst for the company’s medium-lift business, targeting a market expected to exceed 1,000 annual launches by 2030. Management has indicated that research and development expenses will peak around the Neutron rollout, after which operating leverage should drive margins toward a non-GAAP target of 44%. According to internal forecasts, the company anticipates reaching EBITDA breakeven within the next 12 to 18 months, supported by growing Electron launch cadence and early Neutron reservation agreements. Since a buy rating was initiated in November 2024, shares have returned over 550%, and investor focus now shifts to contract backlog, manufacturing scale-up, and the timing of full-reusability certification that underpins the Neutron value proposition.